Knowledge · Natural Compounds

Vitamin B12

Vitamin B12: What 248 human studies show, including 93 randomized controlled trials – organized by area of application and strength of evidence.

Last updated:

We evaluated 248 human studies on Vitamin B12, including 93 randomised controlled trials and 56 meta-analyses or systematic reviews; the controlled studies include 14,539 participants in total. As of 3 October 2026.

This page as PDF · Summary

1. What Is Vitamin B12? Occurrence, Origin and Forms

Vitamin B12 (cobalamin) is a water-soluble vitamin with a cobalt atom at its centre. The body needs it for blood formation, for the nerves and for breaking down homocysteine; it is absorbed in the small intestine only together with intrinsic factor from the stomach.

Only microorganisms make vitamin B12. It occurs in meaningful amounts in animal foods such as meat, liver, fish, eggs and dairy products; plant foods provide hardly any usable vitamin B12.

For supplements, vitamin B12 is produced by bacteria (fermentation). There are tablets, lozenges and sublingual tablets, drops, nasal sprays and intramuscular injections.

Forms and Preparations Studied

  • Cyanocobalamin
  • Methylcobalamin and adenosylcobalamin
  • Hydroxocobalamin, mostly as injection
  • Tablets, sublingual tablets, nasal spray and injection
  • Vitamin B12 combined with folic acid and vitamin B6

Not covered on this page:

  • Studies that measure vitamin B12 blood levels only as a side finding without studying intake or supplementation

2. What Does Vitamin B12 Do? Results by Area

AreaResult in controlled studiesStrength of evidenceStudiesParticipants
Status in vegan diets, older age and with medicationmostly improvedhigh18 meta-analyses · 24 controlled · 43 other2,795
Nerves and nerve damagemostly improvedhigh8 meta-analyses · 24 controlled · 26 other2,302
Homocysteine, heart and blood vesselsmostly improvedhigh8 meta-analyses · 24 controlled · 27 other2,467
Memory and moodmixedhigh7 meta-analyses · 16 controlled · 18 other1,756
Blood formation and anaemiamixedhigh6 meta-analyses · 8 controlled · 14 other2,163
Pregnancy and childrenmixedhigh3 meta-analyses · 4 controlled · 20 other1,599
Other outcomesmostly improvedhigh8 meta-analyses · 53 controlled · 45 other9,028

How to read the table: counted are human studies whose results concern the area. “High” means at least one meta-analysis and two controlled studies showing improvement, or at least three controlled studies of which three quarters show improvement, with at least 300 participants in total. “Moderate” means at least two controlled studies showing improvement, as a majority, or one meta-analysis alongside controlled studies. “Low” means one controlled study showing improvement. Where an area has no controlled study, the strength of evidence is at most “low” (result “reviews only” or “observational data only”). Everything else is “unclear”. A study counts as showing improvement when at least half of its outcomes in this area improved. Reviews of combination products do not count as meta-analyses; results that only describe side effects or shares of users do not count as an effect. The same study is counted only once.

3. What the Studies Show in Detail

Vitamin B12, Status in Vegan Diets, Older Age and with Medication: Human Studies

With a vegan diet without supplementation, reviews and one controlled trial found poorer vitamin B12 blood levels 4851115. Even a partial replacement of animal proteins with plant proteins lowered vitamin B12 status 141. With long-term use of omeprazole, vitamin B12 levels after twelve months were lower than with other acid inhibitors in a controlled trial 136. In metformin-treated type 2 diabetics with vitamin B12 deficiency, oral methylcobalamin or sucrosomial cyanocobalamin normalized the levels in one controlled trial each 91133. Vitamin B12 together with folic acid, sometimes also with vitamin B6, increased vitamin B12 blood levels in meta-analyses 2241. A salt enriched with iodine, iron, folic acid and other micronutrients provided inconsistent findings on vitamin B12 status 23. The strength of evidence is high; what remains open is how well the mostly short studies can be transferred to pregnant women, children or the very old.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
3 Lotti et al. 2026meta-analysis · 48,626 participantsLacto-ovo-vegetarian or vegan diet (vitamin B12 as nutrient); vs. Omnivorous dietVitamin B12 intake: worsened; Vitamin B12 deficiency in vegans: worsened
5 Mazur et al. 2025meta-analysis · 6,098 participantsVitamin B12 sublingual, oral or intramuscular; not reported; dose subgroup analysis showed no dose-response effect; vs. sublingual and oral versus intramuscular injectionSerum cobalamin: improved (pooled mean difference = +402.6 pg/mL; 95% CI: 293.6 to 511.5; p < 0.001); Cobalamin: oral/sublingual versus intramuscular: no difference (p = 0.270)
6 Abdelwahab et al. 2024meta-analysis · 4,275 participantsVitamin B12 (various administration routes); vs. Oral vs. intramuscular vs. sublingualVitamin B12 levels: no difference (MD = 94.09 and 43.31 pg/mL)
7 Larvie et al. 2026systematic review · 4,083 participantsOral vitamin B12 supplementation, alone or with other micronutrients; 0.9 µg/day to 150 µg/day; 28 days to 31 months; vs. PlaceboVitamin B12 deficiency: improved (ARD 56 fewer per 1000, 95% CI 68 fewer to 24 fewer; 1.8% versus 7.6%; RR 0.27, 95% CI 0.11 to 0.69); Total vitamin B12 concentrations: improved (MD 68.53 pmol/L, 95% CI 41.83 to 95.23)
14 Finkelstein et al. 2024systematic review · 984 participantsoral vitamin B12 supplementation; 5 µg/day to 250 µg/day; 8–16 to 32–38 weeks, from 8–28 weeks' gestation; vs. placebo or no vitamin B12 supplementationMaternal vitamin B12 deficiency: improved (25.9% versus 67.9%; RR 0.38, 95% CI 0.28 to 0.51); Total vitamin B12 concentrations: improved (MD 60.89 pmol/L, 95% CI 40.86 to 80.92)
16 Shahid et al. 2025systematic review · 693 participantsProton pump inhibitors (PPIs), not vitamin B12; at least 6 months, up to 12 months; vs. no PPI or baselineSerum vitamin B12: worsened (12-18% reduction in serum vitamin B12 over 12 months)
17 Ménétrier et al. 2023systematic review · 574 participantsNo B12 administration; measurement of total B12, holoTC, tHcy, MMA; vs. No comparison; prevalence of abnormal laboratory valuesProportion with low total vitamin B12: unclear (42.2% (95% confidence interval 37.8-46.6%, n = 486)); Proportion with low holotranscobalamin: unclear (28.6% (7.5-49.6%, n = 21))
18 Wirthensohn et al. 2023systematic review · 292 participants—Maternal B12, exclusive breastfeeding and low-B12 maternal diet predicted infant B12, methylmalonic acid and total homocysteine: unclear

Further studies in this area: 22 23 25 26 28 33 34 39 40 41 47 48 50 51 54 61 62 64 81 85 86 91 92 94 102 112 115 116 119 121 125 127 129 132 133 136 139 141 152 154 155 158 159 160 161 162 163 168 169 170 171 185 186 189 195 201 203 204 205 210 213 214 215 217 218 220 223 224 225 226 227 228 230 231 233 235 237

Vitamin B12, Nerves and Nerve Damage: Human Studies

In type 2 diabetes with neuropathy, nerve conduction, vibration perception and pain improved with oral methylcobalamin over one year, while they worsened with placebo 91. In another study, methylcobalamin worked as well as acetyl-L-carnitine 72. A meta-analysis found better nerve conduction when vitamin B12 was injected into acupuncture points rather than given otherwise 9. After foot or ankle surgery, complex regional pain syndrome occurred less often with methylcobalamin than with placebo 65. During chemotherapy, nerve damage developed less often with vitamin B12 than with placebo 130. In neurological symptoms due to vitamin B12 deficiency, several studies found improvements 203152. A review links a deficiency of vitamin B12 and other nutrients in vegan and vegetarian diets with a higher risk of mental decline 37. The findings are predominantly based on oral methylcobalamin preparations; combinations with alpha-lipoic acid and epalrestat, fasudil, prostaglandin E1, dapagliflozin, herbal medicines or Chinese patent medicine also showed improvements in meta-analyses 1011123246, but cannot be attributed to vitamin B12 alone. What remains open are the optimal form, the best route of administration and the effect in non-diabetic neuropathy.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
4 Lee et al. 2022meta-analysis · 6,260 participantsoral methylcobalamin alone or with herbal medicines; vs. oral methylcobalamin alonesensory nerve conduction velocity (SNCV): improved; motor nerve conduction velocity (MNCV): improved; total efficacy rate (TER): improved
7 Larvie et al. 2026systematic review · 4,083 participantsOral vitamin B12 supplementation, alone or with other micronutrients; 0.9 µg/day to 150 µg/day; 28 days to 31 months; vs. PlaceboMotor skill development (6 to 9 years, NEPSY-II): no difference
9 Yu et al. 2026meta-analysis · 1,688 participantsvitamin B12 via acupoint injection; vs. other administration routes of vitamin B12clinical effectiveness proportion: improved (RR 1.28, 95% CI 1.22-1.35); peroneal nerve motor nerve conduction velocity: improved (MD 4.43, 95% CI 2.83-6.03); peroneal nerve sensory nerve conduction velocity: improved (MD 3.82, 95% CI 3.23-4.41)
10 Ran et al. 2024meta-analysis · 1,153 participantsMecobalamin plus alpha-lipoic acid and epalrestat; vs. Monotherapy or dual therapy with the same drugsTherapeutic outcome (total efficacy): improved (odds ratio: 3.74; 95 % confidence interval: 2.57-5.45; p < 0.00001); Median motor nerve conduction velocity (MNCV): improved; Sensory nerve conduction velocity (SNCV): improved
11 Jiang et al. 2018meta-analysis · 1,148 participantsMethylcobalamin alone or with fasudil; vs. Methylcobalamin monotherapyclinical efficacy: improved (RR 1.26, 95% CI 1.17-1.35, P < .00001); median motor nerve conduction velocity: improved (MD 6.69, 95% CI 4.74-8.64, P < .00001); median sensory nerve conduction velocity: improved (MD 6.71, 95% CI 1.77-11.65, P = .008)
12 Jiang et al. 2018meta-analysis · 1,136 participantsMethylcobalamin plus prostaglandin E1; vs. Prostaglandin E1 monotherapyClinical efficacy: improved (RR 1.25, 95% CI 1.18-1.32, P < .00001); Median motor nerve conduction velocity: improved (MD 6.29, 95% CI 4.63-7.94, P < .00001); Median sensory nerve conduction velocity: improved (MD 5.68, 95% CI 3.53-7.83, P < .00001)
20 Blom et al. 2024systematic review · 50 participantscobalamin (monotherapy); mean 2 months; vs. no control (case series)Disappearance of other neuropsychiatric manifestations: improved (60%)
31 Hamza et al. 2025systematic reviewVitamin B12 supplements, oral or intramuscular; vs. oral versus intramuscular administration; supplementation versus controlNeurological symptoms in overt deficiency: improved; Symptom scores in diabetic neuropathy: improved; Objective neurological measures in diabetic neuropathy: no difference

Further studies in this area: 32 37 44 46 52 53 65 70 72 73 75 83 88 89 91 94 98 103 104 109 121 122 125 130 134 135 142 146 147 150 168 171 175 181 188 189 193 194 197 202 203 208 209 218 222 233 235 239 241 242

Vitamin B12, Homocysteine, Heart and Blood Vessels: Human Studies

In adults with vitamin B12 deficiency, the administration of vitamin B12 lowered the homocysteine blood level; oral and sublingual intake did not perform worse than intramuscular injection 531. Vitamin B12 together with folic acid, sometimes additionally with vitamin B6, also lowered homocysteine, among others in type 2 diabetes, mild cognitive impairment and Alzheimer's disease 222730354143. The strength of evidence is high, but many studies tested only the homocysteine blood level, not heart attacks or strokes.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
2 Ulloque-Badaracco et al. 2023meta-analysis · 87,988 participantsVitamin B12 (level measurement, no supplementation); vs. higher vs. lower vitamin B12 levelsMetabolic syndrome with higher vitamin B12 levels: improved (OR = 0.87; 95% CI: 0.81-0.93; p < 0.01); Metabolic syndrome with higher homocysteine levels: worsened (OR = 1.19; 95% CI: 1.14-1.24; p < 0.01); Metabolic syndrome with higher folate levels: no difference (OR = 0.83; 95% CI: 0.66-1.03; p = 0.09)
5 Mazur et al. 2025meta-analysis · 6,098 participantsVitamin B12 sublingual, oral or intramuscular; not reported; dose subgroup analysis showed no dose-response effect; vs. sublingual and oral versus intramuscular injectionHomocysteine: improved (pooled mean difference = -4.83 μmol/L; 95% CI: -6.55 to -3.11; p < 0.001); Homocysteine: oral/sublingual versus intramuscular: no difference (p = 0.485)
6 Abdelwahab et al. 2024meta-analysis · 4,275 participantsVitamin B12 (various administration routes); vs. Oral vs. intramuscular vs. sublingualHomocysteine levels: no difference
17 Ménétrier et al. 2023systematic review · 574 participantsNo B12 administration; measurement of total B12, holoTC, tHcy, MMA; vs. No comparison; prevalence of abnormal laboratory valuesProportion with elevated homocysteine: unclear (79.7% (75.9-83.5%, n = 429))
22 Liu et al. 2026meta-analysisVitamin B12, alone or with folic acid and vitamin B6; vs. Randomized controlled trials of nutritional supplementsBlood homocysteine level: improved (varying improvements in blood biomarkers, including homocysteine, vitamin B12, and serum folate levels)
27 Li et al. 2025systematic reviewB vitamins (vitamin B6, vitamin B12, partly folate); vs. Control groups of included trialsPlasma homocysteine: improved (effectively reduce plasma homocysteine levels); Thrombotic risk: unclear (remains uncertain)
30 Yin et al. 2025meta-analysisFolic acid plus vitamin B12 (some with vitamin B6); vs. Control (placebo/no supplementation)Serum homocysteine: improved (SMD = -2.77, 95% CI [-3.23, -2.30], P < 0.0001)
31 Hamza et al. 2025systematic reviewVitamin B12 supplements, oral or intramuscular; vs. oral versus intramuscular administration; supplementation versus controlHomocysteine levels: improved

Further studies in this area: 33 35 41 43 48 53 59 68 73 81 85 87 95 97 102 107 110 111 114 115 118 119 123 132 137 145 148 149 150 151 157 159 167 168 170 174 176 177 187 188 190 202 206 211 212 217 229 230 237 243 244

Vitamin B12, Memory and Mood: Human Studies

A systematic review reports that hallucinations in vitamin B12 deficiency improved with vitamin B12 alone 20. Another review links a good vitamin B12 status in pregnant women with better language, better memory and better thinking performance in the children 24. In possible mild cognitive impairment, vitamin B12 brought no advantage for memory and depressive symptoms in a meta-analysis 45. Also in children under twelve years, a systematic review found no difference in thinking performance 7. In adults with mild deficiency without symptoms, another review showed no advantages for thinking and nerves 31. Together with folic acid, the results were inconsistent. In Alzheimer's disease, a meta-analysis found a better MMSE value, but no difference in the ADAS-Cog value 43. In mild cognitive impairment, a randomized study found no difference overall, only with greater brain shrinkage in the left frontal area 68. In older adults, an advantage appeared only with higher blood levels of the omega-3 fatty acid DHA 74. The evidence strength is high, but the result is mixed: forms, groups and measures differ greatly, and it remains open which form and dose benefits whom.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
7 Larvie et al. 2026systematic review · 4,083 participantsOral vitamin B12 supplementation, alone or with other micronutrients; 0.9 µg/day to 150 µg/day; 28 days to 31 months; vs. PlaceboCognitive function (e.g. attention): no difference (SMD 0.09, 95% CI -0.10 to 0.28)
20 Blom et al. 2024systematic review · 50 participantscobalamin (monotherapy); mean 2 months; vs. no control (case series)Full amelioration of hallucinations: improved (75%); Partial amelioration of hallucinations: improved (25%); Therapy-resistant hallucinations fully resolved under cobalamin monotherapy: improved (a quarter of the cases)
24 Franco et al. 2026systematic reviewMaternal vitamin B12 status or supplementation, with vitamin D and folic acid; vs. Children with adequate vs. inadequate maternal vitamin B12 statusLanguage, memory and cognitive performance: improved
31 Hamza et al. 2025systematic reviewVitamin B12 supplements, oral or intramuscular; vs. oral versus intramuscular administration; supplementation versus controlCognitive and neurological outcomes in subclinical deficiency: no difference
41 Zhao et al. 2025meta-analysisVitamin B12 alone or with folate; vs. Network meta-analysis of several interventionsCognitive decline: improved
43 Lee et al. 2024meta-analysisVitamin B12 and folic acid; 6 months; vs. PlaceboMMSE score: improved (SMD = 0.21, 95% CI = 0.01 to 0.32, p = 0.04); ADAS-Cog score: no difference (SMD = 0.06, 95% CI = -0.22 to 0.33, p = 0.68)
45 Alzahrani et al. 2024meta-analysisVitamin B12 supplementation (vitamin B12 complex); vs. Control groups of included RCTsCognitive memory function: no difference (average standardized mean difference of -0.03 (95% confidence interval (CI): -0.07 to 0.01)); Depressive symptoms: no difference (average standardized mean difference of -0.01 (95% CI: -0.0773 to 0.0525))
49 Jembere et al. 2024systematic reviewVitamin B12 (status, dietary intake, supplementation)Children's brain and neurodevelopment: unclear; Cognitive, language and motor development: unclear

Further studies in this area: 52 54 62 68 74 78 90 96 97 99 106 112 113 119 124 127 132 144 163 166 176 177 183 193 194 200 202 218 219 230 231 244 245

Vitamin B12, Blood Formation and Anaemia: Human Studies

In blood formation and anemia, the studies show a mixed picture. For hemoglobin, tablet, sublingual tablet and injection did not differ in a meta-analysis 6. Also in children, administration under the tongue and injection into the muscle yielded the same hemoglobin values 101. Before heart operations, a combination of iron as infusion, erythropoietin, vitamin B12 and folic acid reduced the number of blood transfusions compared with placebo in a randomized study 63. It remains open which form and which route are actually superior in which patient group.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
1 Keats et al. 2021systematic review · 451,723 participantsSingle and multiple micronutrient supplements, including vitamin B12; vs. Supplementation vs. folic acid, iron-folic acid or other controlsMaternal anaemia (IFA vs. folic acid): improved (48% reduction (average RR 0.52, 95% CI 0.41 to 0.66))
6 Abdelwahab et al. 2024meta-analysis · 4,275 participantsVitamin B12 (various administration routes); vs. Oral vs. intramuscular vs. sublingualHemoglobin level: no difference
7 Larvie et al. 2026systematic review · 4,083 participantsOral vitamin B12 supplementation, alone or with other micronutrients; 0.9 µg/day to 150 µg/day; 28 days to 31 months; vs. PlaceboAnaemia: no difference (ARD 21 more per 1000)
14 Finkelstein et al. 2024systematic review · 984 participantsoral vitamin B12 supplementation; 5 µg/day to 250 µg/day; 8–16 to 32–38 weeks, from 8–28 weeks' gestation; vs. placebo or no vitamin B12 supplementationMaternal anaemia: no difference (70.9% versus 65.0%; RR 1.08, 95% CI 0.93 to 1.26)
18 Wirthensohn et al. 2023systematic review · 292 participants—Mean age at first symptoms (anemia, neurological symptoms): unclear (four months)
19 Abe et al. 2016systematic review · 52 participantsMultiple-micronutrient supplement (three or more micronutrients); vs. Placebo or no supplementationMaternal anaemia: improved
20 Blom et al. 2024systematic review · 50 participantscobalamin (monotherapy); mean 2 months; vs. no control (case series)Comorbid pernicious anaemia: unclear (32%)
21 Chen et al. 2026meta-analysisCombined treatment with vitamin B12, iron, EPO, folic acid; vs. Placebo and other interventionsIntraoperative blood loss: improved (MD: 126.33 mL, 95% CrI [23.27, 229.49], P < 0.05)

Further studies in this area: 34 40 61 63 64 80 95 101 102 152 164 169 173 188 195 196 198 203 210 235

Vitamin B12, Pregnancy and Children: Human Studies

In pregnancy, the studies show a mixed picture. Observational studies from India link low vitamin B12 values in pregnant women with more neural tube defects, pregnancy complications and lower birth weight 54. In randomized studies, vitamin B12 promoted the mental development of the children; the effect on birth weight remained open 54. In women undergoing artificial fertilization, a fertility-promoting diet with omega-3, vitamin D, folate and vitamin B12 increased the fertilization rate compared with usual counseling 76. The share of vitamin B12 in this cannot be separated. A meta-analysis found lower vitamin B12 levels in mothers with neural tube defects 38. The evidence strength is high, but the forms and routes examined are inconsistent, and several studies tested vitamin B12 only in combination with other nutrients.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
1 Keats et al. 2021systematic review · 451,723 participantsSingle and multiple micronutrient supplements, including vitamin B12; vs. Supplementation vs. folic acid, iron-folic acid or other controlsLow birthweight (IFA vs. folic acid): improved (12% reduction (average RR 0.88, 95% CI 0.78 to 0.99)); Low birthweight (MMN vs. iron with or without FA): improved (15% (average RR 0.85, 95% CI 0.77 to 0.93)); Stillbirths (MMN): improved (average RR 0.91; 95% CI 0.86)
14 Finkelstein et al. 2024systematic review · 984 participantsoral vitamin B12 supplementation; 5 µg/day to 250 µg/day; 8–16 to 32–38 weeks, from 8–28 weeks' gestation; vs. placebo or no vitamin B12 supplementationPreterm birth: unclear (RR 0.97, 95% CI 0.55 to 1.74); Low birthweight: unclear (RR 1.50, 95% CI 0.93 to 2.43)
24 Franco et al. 2026systematic reviewMaternal vitamin B12 status or supplementation, with vitamin D and folic acid; vs. Children with adequate vs. inadequate maternal vitamin B12 statusChild neurodevelopment: improved
38 Nie et al. 2025meta-analysisMaternal blood vitamin B12 (no supplement given); vs. Neural tube defect group vs. non-NTD controlsMaternal blood vitamin B12 level in neural tube defects: worsened (SMD = -0.23, 95% CI (-0.32, -0.14), p < 0.001); Vitamin B12 level in NTD with no folate difference: worsened (SMD: -0.19, 95% CI (-0.28, -0.10))
54 Behere et al. 2021systematic reviewVitamin B12 (form not specified); vs. low vs. higher maternal B12 status; supplementation vs. controlneural tube defects: improved; pregnancy complications: improved; birth weight: improved
58 Kvestad et al. 2026randomised controlled · 800 participantsvitamin B-12 or placebo; from early pregnancy to 6 months postpartum; vs. placeboInfant motor development (TIMP score): worsened; Interaction with plasma folate: unclear (P-interaction = 0.015)
62 Nagpal et al. 2026randomised controlled · 531 participantsDaily oral methylcobalamin; 250 µg (group A) vs. 50 µg (group B); From enrolment to 6 months post partum; vs. Higher dose 250 µg versus lower dose 50 µgNewborn anthropometry, APGAR scores and morbidity: no difference (p>0.05)
76 Ghadimi et al. 2026randomised controlled · 180 participantsPro-fertility diet plus supplement combination with vitamin B12; vitamin B12 500 µg/day; 60 days; vs. general dietary advice plus 500 µg/day folic acidfertilization rate: improved (0.81 ± 0.16 versus 0.66 ± 0.24; P < 0.001); embryo formation rate: improved (0.79 ± 0.26 versus 0.62 ± 0.30; P < 0.001); number of embryos formed: improved (3.78 ± 2.34 versus 2.22 ± 1.46; P < 0.001)

Further studies in this area: 93 158 161 162 164 175 181 182 184 187 190 191 192 200 216 221 228 232 236

Vitamin B12: Further Outcomes in Studies

Oral methylcobalamin improved quality of life in a controlled study in type 2 diabetics with long-term metformin intake and diabetic neuropathy 91. For linear growth in children, a systematic review found no difference from placebo 7. For quality of life under oral cyanocobalamin, a controlled study found no difference 130. The evidence strength is high; most of these studies tested methylcobalamin, and it is open whether other forms act the same.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
7 Larvie et al. 2026systematic review · 4,083 participantsOral vitamin B12 supplementation, alone or with other micronutrients; 0.9 µg/day to 150 µg/day; 28 days to 31 months; vs. PlaceboHeight/length: no difference (MD -0.19 cm, 95% CI -2.44 to 2.06)
8 Kuo et al. 2025meta-analysis · 1,723 participantsTopical vitamin B12 (cobalamin), partly with vitamins D3, E, B3; vs. PlaceboPruritus severity (all vitamins combined): improved (SMD: -0.578, 95% CI: -0.736 to -0.419, p = 0.000); Pruritus severity (topical vitamin B12 subgroup): improved
9 Yu et al. 2026meta-analysis · 1,688 participantsvitamin B12 via acupoint injection; vs. other administration routes of vitamin B12fasting blood glucose: no difference (MD -0.18, 95% CI -0.44 to 0.08); 2-h postprandial blood glucose: no difference (MD -0.02, 95% CI -0.36 to 0.33); adverse event incidence (RR 1.44, 95% CI 0.44-4.70)
10 Ran et al. 2024meta-analysis · 1,153 participantsMecobalamin plus alpha-lipoic acid and epalrestat; vs. Monotherapy or dual therapy with the same drugsAdverse effects (No statistic difference)
13 Li et al. 2025meta-analysis · 1,130 participantsFolate and vitamin B12 (dietary intake or serum levels); vs. lower versus higher intake/levelsHPV persistence and CIN progression: improved (SMD = 0.80 [0.65, 0.95]; p < 0.00001; I2 = 0%; GRADE: High)
15 Gupta et al. 2021systematic review · 701 participantsVitamin B12 among other agents; vs. Placebo or other agentsHearing outcome in noise-induced hearing loss: unclear
16 Shahid et al. 2025systematic review · 693 participantsProton pump inhibitors (PPIs), not vitamin B12; at least 6 months, up to 12 months; vs. no PPI or baselineCalcium and parathyroid hormone: worsened (declined significantly in a 12-month cohort); Bone turnover markers: worsened (increased despite stable bone mineral density); Magnesium status: unclear (ranging from no change after 12 months to pharmacokinetic alterations without systemic depletion)
17 Ménétrier et al. 2023systematic review · 574 participantsNo B12 administration; measurement of total B12, holoTC, tHcy, MMA; vs. No comparison; prevalence of abnormal laboratory valuesProportion with increased methylmalonic acid: unclear (79.6% (71.5-87.7%, n = 98))

Further studies in this area: 18 29 30 32 35 36 40 42 43 54 55 56 57 60 61 62 64 65 66 67 69 71 77 79 82 83 84 86 87 90 91 92 94 95 97 99 100 103 104 105 108 109 111 115 116 117 119 120 121 122 123 124 126 127 128 130 131 134 137 138 140 142 143 144 148 151 153 156 165 167 169 172 173 174 175 176 178 179 180 181 182 183 189 193 199 204 207 212 217 218 219 230 233 234 238 240 242 243

4. How Is Vitamin B12 Dosed? Preparation, Dose and Duration in Studies

The studies predominantly used oral, sublingual, intranasal, intramuscular, intravenous and subcutaneous preparations of cyanocobalamin, methylcobalamin, adenosylcobalamin and hydroxocobalamin. Methylcobalamin, also called mecobalamin, was mostly used as a tablet, sometimes also as a gel for application. Several studies tested vitamin B12 only as a component of mixtures, for example with folic acid and vitamin B6, with iron and folic acid or with other micronutrients.

Preparation or formDoseDurationStudy
Cyanocobalamin plus folate and vitamin B6, optionally with omega-3 fatty acidsCyanocobalamin 0.02 mg, folate 0.56 mg, vitamin B6 3 mg daily5 years57
vitamin B-12 or placebo—from early pregnancy to 6 months postpartum58
Vitamin B12 (1.8 µg) and/or folic acid (150 µg)1.8 µg vitamin B12, 150 µg folic acid daily6 months supplementation, follow-up after 6-7 years59
Vitamin B12 (about 2 RDA) and/or folic acid (about 2 RDA) or placeboabout 2 RDA daily6 months supplementation, follow-up 6 years later60
Lipid-based nutrient supplement (LNS) with milk/soy protein and whey permeate/maltodextrin100 g per day12 weeks61
Daily oral methylcobalamin250 µg (group A) vs. 50 µg (group B)From enrolment to 6 months post partum62
1 mg vitamin B12 subcutaneously plus iron, erythropoietin, folic acid1 mg vitamin B12 subcutaneously once on the day before surgerySingle dose on the day before surgery63
Quintuply-fortified salt (QFS) with vitamin B12—12 months64
Mecobalamin (methylcobalamin) versus placebo—12 months follow-up65
Intramuscular ultra-high-dose methylcobalamin25 mg or 50 mgup to week 18266
Topical methylcobalamin gel 6% w/w—12 sessions over four weeks67
500 µg methylcobalamin plus 400 µg folic acid or placebo500 µg methylcobalamin and 400 µg folic acid daily24 months, follow-up at 12 and 24 months68
Folic acid 400 µg + vitamin B12 5 µg or placebo400 µg folic acid + 5 µg B12 daily12 weeks69
vitamin B1-6-12 combination or vitamin B12 alone—4 and 12 weeks70
oral methylcobalamin versus placebo0.5 mg orally, three times dailymaximum 24 weeks71

5. Is Vitamin B12 Safe? Side Effects in Studies

The studies predominantly report good tolerability of vitamin B12 in the forms and routes investigated. A review on strongly elevated vitamin B12 levels describes antibodies against the transport protein transcobalamin II after supplementation 25.

StudyReported side effects
4 Lee et al. 2022relatively safe
7 Larvie et al. 2026Adverse effects assessed as critical outcome
9 Yu et al. 2026no significant difference in adverse events (RR 1.44, 95% CI 0.44-4.70)
10 Ran et al. 2024No statistical difference in adverse effects
11 Jiang et al. 2018no serious adverse events
12 Jiang et al. 2018No serious adverse events with combination therapy
14 Finkelstein et al. 2024spontaneous abortion reported, no quantitative data; no clear definition
16 Shahid et al. 2025vitamin B12 and calcium depletion, inconsistent magnesium findings
19 Abe et al. 2016not reported
25 Fernández-Téllez et al. 2026Formation of anti-transcobalamin II autoantibodies after supplementation
30 Yin et al. 2025Overall incidence and types of diabetes-related complications
31 Hamza et al. 2025oral therapy better tolerated than intramuscular injections

6. What Remains Open: Limits of the Evidence

  • Many studies are short and investigate different forms and routes of administration, which makes direct comparison difficult.
  • The transferability to special groups such as pregnant women, children or the very old remains open.
  • For the heart and blood vessels, many studies tested only the homocysteine blood level as an intermediate marker, not hard cardiovascular endpoints.
  • For memory and mood, the populations and outcome measures are very heterogeneous, so no uniform statement is possible.

7. Bottom Line: What Is Established About Vitamin B12

In controlled trials, vitamin B12 reliably improves vitamin B12 biomarkers in the blood, regardless of whether it is given orally, sublingually or intramuscularly. For nerve damage due to diabetes and for the homocysteine blood level, improvements are also predominantly seen with methylcobalamin or vitamin B12. With a vegan diet without supplementation and with long-term use of proton pump inhibitors, however, the supply is poorer.

The situation is less uniform for memory, mood, blood formation and in pregnancy: here improvements and results without difference stand side by side. Many studies also tested vitamin B12 only in combination with other nutrients, and several were short or investigated different forms and routes. Tolerability is predominantly described as good.

Frequently Asked Questions

How well has Vitamin B12 been studied in humans?

We evaluated 248 human studies on Vitamin B12, including 93 randomised controlled trials and 56 meta-analyses or systematic reviews; the controlled studies include 14,539 participants in total. As of 3 October 2026.

Does Vitamin B12 help with status in vegan diets, older age and with medication? What the studies show

We evaluated 18 meta-analyses or systematic reviews, 24 controlled studies and 43 further studies; the controlled studies include 2,795 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: high. Sources: 3567

Does Vitamin B12 help with nerves and nerve damage? What the studies show

We evaluated 8 meta-analyses or systematic reviews, 24 controlled studies and 26 further studies; the controlled studies include 2,302 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: high. Sources: 47910

Does Vitamin B12 help with homocysteine, heart and blood vessels? What the studies show

We evaluated 8 meta-analyses or systematic reviews, 24 controlled studies and 27 further studies; the controlled studies include 2,467 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: high. Sources: 25617

Does Vitamin B12 help with memory and mood? What the studies show

We evaluated 7 meta-analyses or systematic reviews, 16 controlled studies and 18 further studies; the controlled studies include 1,756 participants in total. Result of the controlled studies: mixed. Strength of evidence under our published rules: high. Sources: 7202431

Does Vitamin B12 help with blood formation and anaemia? What the studies show

We evaluated 6 meta-analyses or systematic reviews, 8 controlled studies and 14 further studies; the controlled studies include 2,163 participants in total. Result of the controlled studies: mixed. Strength of evidence under our published rules: high. Sources: 16714

Does Vitamin B12 help with pregnancy and children? What the studies show

We evaluated 3 meta-analyses or systematic reviews, 4 controlled studies and 20 further studies; the controlled studies include 1,599 participants in total. Result of the controlled studies: mixed. Strength of evidence under our published rules: high. Sources: 1142438

Which forms of vitamin B12 were investigated in the studies?

Mainly cyanocobalamin, methylcobalamin, adenosylcobalamin and hydroxocobalamin were investigated. Methylcobalamin, also called mecobalamin, was mostly used as a tablet, sometimes also as a gel for application. Hydroxocobalamin was mostly given as an injection.

Does vitamin B12 work with a vegan diet?

With a vegan diet without supplementation, reviews and one controlled trial found poorer vitamin B12 blood levels 4851115. Even a partial replacement of animal proteins with plant proteins lowered vitamin B12 status 141.

Does vitamin B12 help with nerve damage?

In diabetic neuropathy, nerve conduction, vibration perception and pain improved with oral methylcobalamin over one year, while they worsened with placebo 91.

Does vitamin B12 lower the homocysteine blood level?

In adults with vitamin B12 deficiency, the administration of vitamin B12 lowered the homocysteine blood level; oral and sublingual intake did not perform worse than intramuscular injection 531. Vitamin B12 together with folic acid, sometimes additionally with vitamin B6, also lowered homocysteine 222730354143. However, many studies tested only the homocysteine blood level as an intermediate marker, not hard cardiovascular endpoints.

How tolerable is vitamin B12?

The studies predominantly report good tolerability. A review on strongly elevated vitamin B12 levels describes antibodies against the transport protein transcobalamin II after supplementation 25.

Sources

  1. 1
  2. 2
    Ulloque-Badaracco JR, Hernandez-Bustamante EA, Alarcon-Braga EA, Al-Kassab-Córdova A, Cabrera-Guzmán JC, Herrera-Añazco P et al. · 2023
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
    Larvie DY, Güitrón Leal CE, Venkatramanan S, Palma Molina XE, Steel LB, Kuriyan R et al. · 2026
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
    Finkelstein JL, Fothergill A, Venkatramanan S, Layden AJ, Williams JL, Crider KS et al. · 2024
  15. 15
    Gupta A, Koochakzadeh S, Nguyen SA, Brennan EA, Meyer TA, Lambert PR · 2021
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
    Fernández-Téllez B, Franco-Rico JA, Valdez-Martínez E · 2026
  26. 26
  27. 27
  28. 28
  29. 29
    Habtie TE, Zemariam AB, Dagnaw BW, Alamaw AW, Feleke SF, Adisu MA · 2025
  30. 30
  31. 31
    Hamza Ali AA, Mohamed FHA, Hago S, Elsadig Elgali IF, Sherfeldin Mohammed HE, Mirghani RG · 2025
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
    Clemente-Suárez VJ, Redondo-Flórez L, Martín-Rodríguez A, Curiel-Regueros A, Rubio-Zarapuz A, Tornero-Aguilera JF · 2025
  38. 38
  39. 39
  40. 40
    Akinwumi FE, Akinyemi AO, Akangbe B, Odeniran OM, Sehkar J, Olajimbiti CO et al. · 2025
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
    Bärebring L, Lamberg-Allardt C, Thorisdottir B, Ramel A, Söderlund F, Arnesen EK et al. · 2023
  51. 51
    Koller A, Rohrmann S, Wakolbinger M, Gojda J, Selinger E, Cahova M et al. · 2023
  52. 52
  53. 53
  54. 54
  55. 55
    Nattagh-Eshtivani E, Sani MA, Dahri M, Ghalichi F, Ghavami A, Arjang P et al. · 2018
  56. 56
    Meolie AL, Rosen C, Kristo D, Kohrman M, Gooneratne N, Aguillard RN et al. · 2005
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
    Amato B, Compagna R, Amato M, Gallelli L, de Franciscis S, Serra R · 2015
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
    van der Burg KP, Cribb L, Firth J, Karmacoska D, Mischoulon D, Byrne GJ et al. · 2020
  79. 79
  80. 80
  81. 81
    Savic-Hartwig M, Kerlikowsky F, van de Flierdt E, Hahn A, Schuchardt JP · 2024
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
    Li C, Mao W, Zhang L, Zhang X, Wu H, Zhang G et al. · 2024
  91. 91
    Didangelos T, Karlafti E, Kotzakioulafi E, Margariti E, Giannoulaki P, Batanis G et al. · 2021
  92. 92
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97
  98. 98
  99. 99
  100. 100
  101. 101
  102. 102
  103. 103
  104. 104
  105. 105
  106. 106
    Schneider N, Bruchhage MMK, O'Neill BV, Hartweg M, Tanguy J, Steiner P et al. · 2022
  107. 107
  108. 108
  109. 109
  110. 110
    Association of Plasma Folate, Vitamin B12, and Betaine With Total Homocysteine in Pregnancy, and Effect Modification Due to Folic Acid Versus Natural Folate Supplementation
    · 2022
  111. 111
    Kirsch SH, Herrmann W, Kruse V, Eckert R, Gräber S, Geisel J et al. · 2015
  112. 112
  113. 113
  114. 114
  115. 115
    Lederer AK, Hannibal L, Hettich M, Behringer S, Spiekerkoetter U, Steinborn C et al. · 2019
  116. 116
  117. 117
  118. 118
    Ghandour H, Bagley PJ, Shemin D, Hsu N, Jacques PF, Dworkin L et al. · 2002
  119. 119
  120. 120
  121. 121
  122. 122
  123. 123
    Collins PB, Earnest CP, Dalton RL, Sowinski RJ, Grubic TJ, Favot CJ et al. · 2017
  124. 124
  125. 125
  126. 126
  127. 127
  128. 128
  129. 129
    Kashyap S, Gowda P, Pasanna RM, Sivadas A, Sachdev HS, Kurpad AV et al. · 2024
  130. 130
  131. 131
    Santos SS, da Costa LATJ, Araripe TSO, Reges BDLO, Ximenes HMA, Moreira ACOM · 2026
  132. 132
  133. 133
  134. 134
  135. 135
  136. 136
  137. 137
  138. 138
  139. 139
  140. 140
  141. 141
  142. 142
  143. 143
  144. 144
  145. 145
    Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial
    Mazza A, Cicero AF, Ramazzina E, Lenti S, Schiavon L, Casiglia E et al. · 2016
  146. 146
  147. 147
    [Clinical observation of post-herpetic neuralgia treated with TCM herbal cupping therapy]
    Wu X, Hu H, Guo L, Wang H · 2013
  148. 148
  149. 149
  150. 150
    Prognostic Impact of Serum Homocysteine-Lowering Therapy on Patients with Hemorrhagic Stroke and Its Influence on National Institutes of Health Stroke Scale and China Stroke Scale Scores
    An X, Du X, Yang B, Zhai N, Cui L · 2024
  151. 151
  152. 152
  153. 153
  154. 154
  155. 155
    Aboshaiqah A, Aboshaiqah B, Alharbi NM, Almunyif TI, Binghanim SD, Almejalli AK · 2024
  156. 156
  157. 157
    Eken Y, Tekin N, Şahin F, Tay İ, Yıldırım Saral N, Serteser M et al. · 2026
  158. 158
    Cruz-Rodríguez J, Canals-Sans J, Jardí C, Arija V · 2026
  159. 159
    Bjørkevoll SMG, O'Keeffe M, Konijnenberg C, Solvik BS, Sødal AF, Kaldenbach S et al. · 2025
  160. 160
    Schwinger C, Sharma S, Chandyo RK, Hysing M, Kvestad I, Ulak M et al. · 2021
  161. 161
  162. 162
  163. 163
    Domínguez-López I, Casas R, Chiva-Blanch G, Martínez-González MÁ, Fitó M, Ros E et al. · 2023
  164. 164
    Gοugοutsi V, Pouliakis A, Argyrios T, Tolia M, Nazos NA, Panagopoulos P et al. · 2024
  165. 165
  166. 166
  167. 167
  168. 168
  169. 169
  170. 170
  171. 171
  172. 172
  173. 173
    Souissi S, Ayari M, Abdellali I, Bourguiba R, Belakhal S, Jomni T et al. · 2024
  174. 174
  175. 175
    Stepien KM, Sykut-Cegielska J, Sloan J, Piazzon F, Bick S, Bouchereau J et al. · 2026
  176. 176
  177. 177
  178. 178
  179. 179
  180. 180
  181. 181
    Huemer M, Simma B, Fowler B, Suormala T, Bodamer OA, Sass JO · 2005
  182. 182
  183. 183
    Lopez-Ruiz AA, Anastopulos FD, Trinchet LP, Maloney J, Wie C, Viswanath O et al. · 2026
  184. 184
    Andonotopo W, Bachnas MA, Dewantiningrum J, Adi Pramono MB, Sulistyowati S, Hariyasa Sanjaya IN et al. · 2026
  185. 185
    Marandola M, Napoli G, Leggeri S, Lombardi C, Urbani A, Baroni S · 2026
  186. 186
  187. 187
  188. 188
  189. 189
    Pancheva R, Dzhogova M, Dimitrov L, Nikolova M, Mihaylova G, Panayotova V et al. · 2026
  190. 190
    Mathew AR, Selita E, Regano C, Bianco C, Corsetti V, Cavallucci V et al. · 2026
  191. 191
  192. 192
  193. 193
    Papazachariou A, Papakitsou I, Malikides V, Filippatos TD · 2026
  194. 194
  195. 195
  196. 196
  197. 197
    Umar M, Franjieh K, White AL, Ward-Dones E, Ismael S, Roskey RC et al. · 2026
  198. 198
  199. 199
  200. 200
    Zwierz M, Suprunowicz M, Mrozek K, Pietruszkiewicz J, Oracz AJ, Konarzewska B et al. · 2025
  201. 201
  202. 202
    Han A, Almeida L, Anand N, Salloum IM, Kanaan S, Gadad BS et al. · 2025
  203. 203
  204. 204
  205. 205
  206. 206
    Huang L, Huhulea EN, Enwere C, Aifuwa E, Frishman WH, Aronow WS · 2025
  207. 207
  208. 208
  209. 209
  210. 210
    Robinson SR, Trivedi MS, Fayet-Moore F · 2025
  211. 211
  212. 212
  213. 213
  214. 214
    Carretero-Krug A, Montero-Bravo A, Morais-Moreno C, Puga AM, Samaniego-Vaesken ML, Partearroyo T et al. · 2024
  215. 215
    Fernandes S, Oliveira L, Pereira A, Costa MDC, Raposo A, Saraiva A et al. · 2024
  216. 216
    Sfakianoudis K, Zikopoulos A, Grigoriadis S, Seretis N, Maziotis E, Anifandis G et al. · 2024
  217. 217
    Simonenko SY, Bogdanova DA, Kuldyushev NA · 2024
  218. 218
    Rekik A, Santoro C, Poplawska-Domaszewicz K, Qamar MA, Batzu L, Landolfo S et al. · 2024
  219. 219
    Kennedy KP, Alexander JL, Garakani A, Gross LS, Mintz DL, Parikh T et al. · 2024
  220. 220
  221. 221
    Arcot A, Walker RE, Gallagher K, Klatt KC, Gernand AD · 2024
  222. 222
  223. 223
    Sandoval Leiva T, Muñoz Y, Tabilo Aguirre L, Estay Castillo P · 2024
  224. 224
    Łuszczki E, Boakye F, Zielińska M, Dereń K, Bartosiewicz A, Oleksy Ł et al. · 2023
  225. 225
  226. 226
  227. 227
  228. 228
  229. 229
  230. 230
  231. 231
    Lauer AA, Grimm HS, Apel B, Golobrodska N, Kruse L, Ratanski E et al. · 2022
  232. 232
  233. 233
    Pyrgioti EE, Karakousis ND · 2022
  234. 234
  235. 235
  236. 236
  237. 237
    Marrone G, Guerriero C, Palazzetti D, Lido P, Marolla A, Di Daniele F et al. · 2021
  238. 238
  239. 239
    Cordaro M, Siracusa R, Fusco R, Cuzzocrea S, Di Paola R, Impellizzeri D · 2021
  240. 240
  241. 241
    [Extra hospital use of nitrous oxide for recreational purposes]
    Domont P, Debaize S · 2020
  242. 242
    Buesing S, Costa M, Schilling JM, Moeller-Bertram T · 2019
  243. 243
  244. 244
  245. 245

Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.

International Health Research · https://ih-research.com/en/knowledge/vitamin-b12/ · Last updated: 2026-10-15